AutoCore: network-based definition of the core module of human autoimmunity and autoinflammation
Data files
Sep 06, 2023 version files 32.63 MB
-
README.md
2.10 KB
-
Supplementary_File_1.txt
12.48 MB
-
Supplementary_File_10_new.txt
2.56 KB
-
Supplementary_File_11_new.txt
341.43 KB
-
Supplementary_File_12_new.txt
52.29 KB
-
Supplementary_File_13_new_header.xlsx
861.64 KB
-
Supplementary_File_14_new.xlsx
29.19 KB
-
Supplementary_File_15_revised.xlsx
209.79 KB
-
Supplementary_File_16.xlsx
454.31 KB
-
Supplementary_File_17.txt
75.22 KB
-
Supplementary_File_18.cys
311.60 KB
-
Supplementary_File_19.txt
134.29 KB
-
Supplementary_File_2.txt
10.25 KB
-
Supplementary_File_20.cys
191.01 KB
-
Supplementary_File_21.cys
100 KB
-
Supplementary_File_3.txt
57.90 KB
-
Supplementary_File_4.txt
41.56 KB
-
Supplementary_File_5.txt
58.14 KB
-
Supplementary_File_6.xlsx
17.13 MB
-
Supplementary_File_7.txt
6.25 KB
-
Supplementary_File_8.xlsx
66.49 KB
-
Supplementary_File_9.xlsx
13.47 KB
Abstract
Although research on rare autoimmune and autoinflammatory diseases has enabled definition of non-redundant regulators of homeostasis in human immunity, due to the single gene-single disease nature of many of these diseases, contributing factors were mostly unveiled in sequential and non-coordinated individual studies. Here, we used a network-based approach for integrating a set of 186 inborn errors of immunity with predominant autoimmunity/autoinflammation into a comprehensive map of human immune dysregulation which we termed “AutoCore”. The AutoCore is located centrally within the interactome of all protein-protein interactions, connecting and pinpointing multi-disease markers for a range of common, polygenic autoimmune/autoinflammatory diseases. The AutoCore can be subdivided into 19 endotypes that correspond to molecularly and phenotypically cohesive disease subgroups, providing a molecular mechanism-based disease classification and rationale towards systematic targeting for therapeutic purposes. Our study provides a proof-of-concept for using network-based methods to systematically investigate the molecular relationships between individual rare diseases and address a range of conceptual, diagnostic, and therapeutic challenges.